StoneCalibre Acquires Specialty Detergent and Synthetic Lipid Manufacturer Anatrace From Affymetrix

StoneCalibre Acquires Specialty Detergent and Synthetic Lipid Manufacturer 
Anatrace From Affymetrix 
Industry: Life Sciences 
LOS ANGELES, CA -- (Marketwired) -- 10/14/13 --  StoneCalibre today
announced the completion of the acquisition of Anatrace, a part of
Affymetrix, Inc. (NASDAQ: AFFX). Headquartered in Maumee, Ohio,
Anatrace is a highly specialized developer, manufacturer and global
distributor of unique, high purity detergents and synthetic lipids
for use in membrane protein studies.  
Established in 1985, Anatrace has built the broadest portfolio of
detergents and lipids available in the marketplace with a core
competency of developing and manufacturing creative solutions for
stabilizing and solubilizing macromolecules. 
"Anatrace is a high quality company offering a value-add product that
is mission critical to its customer base," said Brian Wall, Founder
and Chief Executive Officer of StoneCalibre. "We are confident that
as a standalone company, Anatrace will continue to build on its
tradition of collaborating with its global customer base to help
answer critical questions in the advancement of important studies
across multiple scientific fields including cancer research." 
"StoneCalibre has been a great partner for us through this process,"
said Frank Witney, Chief Executive Officer of Affymetrix. "Their
corporate carve-out experience and ability to offer speed and
certainty around the sale process were critical factors for us. We
feel that StoneCalibre will provide a great long-term home for
Anatrace and its devoted employee base." 
Ben Travis, the newly appointed CEO of Anatrace, expressed his
enthusiasm for partnering with StoneCalibre. "Anatrace's passion for
detergents and lipids, combined with StoneCalibre's strategic and
financial support, will help drive the company to higher levels of
excellence and allow us to capitalize on future growth
opportunities." 
Anatrace is StoneCalibre's second acquisition in the last five
months. The terms of the transaction were not disclosed. EMA Partners
acted as the exclusive financial advisor to Affymetrix. 
About StoneCalibre 
Headquartered in Century City, CA, StoneCalibre is a privately funded
investment firm specializing in the acquisition of lower middle
market companies. Founded by Brian Wall in 2012, StoneCalibre is
focused on making investments in both special situations and quality
long-term capital investment opportunities. For more information
please visit our website at www.stonecalibre.com. 
About Affymetrix 
Affymetrix technologies enable multiplex and simultaneous analysis of
biological systems at the cell, protein, and gene level, facilitating
the rapid translation of bench-top research into clinical and routine
use for human health and wellness.  
Affymetrix strives to provide leadership and support, partnering with
customers in pharmaceutical, diagnostic, and biotechnology companies,
as well as leading academic, government, and non-profit research
institutes in their quest for answers toward using biology for a
better world.  
More than 2,300 microarray systems have been shipped around the world
and more than 48,000 peer-reviewed papers have been published citing
these technologies. Affymetrix is headquartered in Santa Clara,
California, and has manufacturing facilities in Cleveland, Ohio, San
Diego, Vienna and Singapore. The Company has about 1,100 employees
worldwide and maintains sales and distribution operations across
Europe, Asia, and Latin America. For more information about
Affymetrix, please visit www.affymetrix.com.  
For more information please contact: 
Nick Matzke
Business Development
StoneCalibre, LLC
Phone: (310) 774-0376
Fax: (310) 427-7448
nmatzke@stonecalibre.com 
 
 
Press spacebar to pause and continue. Press esc to stop.